BLK and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, there is evidence that BLK can inhibit tumor progression, i.e., in a mouse model, it inhibits the progress of chronic myeloid leukemia via increasing the expression of p27 (Zhang et al., 2012b).